K. Brittany Bradrick's most recent trade in Dermata Therapeutics Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Dermata Therapeutics Inc | Brittany K. Bradrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
Dermata Therapeutics Inc | K. Brittany Bradrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Dermata Therapeutics Inc | Brittany K. Bradrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 8,602 | 13,633 | - | 0 | Common Stock, par value $0.0001 per share | |
Dermata Therapeutics Inc | Brittany K. Bradrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 5,031 | 5,031 | - | 0 | Common Stock, par value $0.0001 per share | |
Dermata Therapeutics Inc | Brittany K. Bradrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to Buy) |